Skip to main content
Youcare Pharmaceutical Group Co.,Ltd. logo

Youcare Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 688658 ISIN · CNE100005XQ2 LEI · 300300PGECIYG6664670 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 629 across all filing types
Latest filing 2026-03-20 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 688658

About Youcare Pharmaceutical Group Co.,Ltd.

https://www.youcareyk.com/

Youcare Pharmaceutical Group Co., Ltd. is an integrated enterprise engaged in the research, development, manufacturing, and marketing of pharmaceutical products. The organization focuses on therapeutic areas such as cardiovascular and cerebrovascular diseases, digestive health, anti-infectives, and endocrine disorders. Its portfolio includes chemical drugs, modern traditional Chinese medicines, and biological preparations, with notable products like Ginkgo Biloba Extract Injection. The company maintains a comprehensive industrial chain, covering the production of active pharmaceutical ingredients and finished dosage forms. By prioritizing technological innovation and quality control, the group provides medical solutions to clinical and retail sectors. Its operations are supported by large-scale production bases and a dedicated research infrastructure aimed at developing both high-end generic and innovative medications.

Recent filings

Filing Released Lang Actions
关于公司2025年度募集资金存放、管理与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the company's fundraising activities for the year 2025, including the storage, management, and actual use of the raised funds. It references regulatory rules related to fundraising, provides detailed financial figures on fundraising amounts, usage, balances, and investment projects, and includes auditor and sponsor opinions on the fundraising fund management. The document is lengthy (over 14,000 characters) and contains substantive financial data and analysis related to fundraising activities. It is not an announcement of a report but the report itself. The content matches the description of a Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. Therefore, the appropriate classification is CAP.
2026-03-20 Chinese
董事会审计委员会2025年度履职情况报告（公告版）_3.20
Audit Report / Information Classification · 95% confidence The document is titled as a "Board Audit Committee 2025 Annual Performance Report" from a company's audit committee. It details the audit committee's composition, meetings held during 2025, oversight of external and internal audits, review of financial reports, internal control evaluations, and communication with auditors. The content focuses on the audit committee's activities and their evaluation of audit work and internal controls for the year 2025. It is a report on the audit committee's duties and performance rather than a full annual report or standalone audit report. The document length is 2642 characters, which is relatively short but contains substantive content about audit committee activities and evaluations. This fits best with the category of Audit Report / Information (AR), which includes audit reports, applied accounting principles, and results of internal or regulatory stress tests, excluding full annual reports. It is not an announcement or certification, so it is not RNS or RPA. It is not a management report or governance report. Therefore, the classification is AR with high confidence. FY 2025
2026-03-20 Chinese
2025年度内部控制评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Internal Control Evaluation Report" for the year ending December 31, 2025, issued by the company's board and management. It discusses the effectiveness of internal controls over financial reporting and non-financial reporting, the scope of evaluation, defect identification standards, and remediation status. It is a detailed report on internal control evaluation rather than a general annual report or audit report. The document is about internal control evaluation, which is typically classified under Audit Report / Information (AR) as it relates to internal control effectiveness and audit committee oversight. The document length is 4393 characters, which is sufficient to be the report itself, not just an announcement. There is no indication that this is a certification letter or a brief announcement. Therefore, the best fitting category is AR (Audit Report / Information). FY 2025
2026-03-20 Chinese
董事和高级管理人员薪酬管理制度
Remuneration Information Classification · 95% confidence The document is a detailed policy document outlining the remuneration management system for the company's directors and senior management. It includes principles, standards, composition, payment, adjustment, and related governance of compensation. It does not contain financial statements, audit results, or earnings data. It is not an announcement or a brief summary but a comprehensive governance-related document. The content aligns with remuneration information disclosures about executive and director compensation policies and procedures. Therefore, the document fits the Remuneration Information category (DEF 14A). The document length is 2842 characters, which is sufficient for a detailed policy but not a full financial report. No indication of it being a report publication announcement or regulatory filing. Hence, classification as DEF 14A is appropriate with high confidence.
2026-03-20 Chinese
公司关于会计师事务所履职情况的评估报告
Audit Report / Information Classification · 95% confidence The document is titled as an evaluation report on the performance of the accounting firm (auditor) for the year 2025. It discusses the auditor's qualifications, audit procedures, quality control, and overall assessment of the auditor's work for the company's 2025 annual audit. It does not contain the actual audited financial statements or detailed financial results but rather an assessment of the auditor's performance and compliance with regulations. This type of document is a standalone audit-related report, not the full annual report or audit opinion itself. Therefore, it fits the category of Audit Report / Information (AR). The document length is 3263 characters, which is sufficient for a detailed audit evaluation report but not a full annual report. Hence, the classification is AR with high confidence. FY 2025
2026-03-20 Chinese
关于续聘公司2026年度审计机构的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the reappointment of the company's audit firm for the fiscal year 2026. It details the audit firm's background, personnel, integrity records, independence, and audit fees. It also describes the board audit committee's and board's approval process for the reappointment. The document does not contain any actual audit report or financial statements but is an announcement about the audit firm appointment for the upcoming year. The document length is 2569 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document fits best under the category of Audit Report / Information (AR), as it relates specifically to audit firm appointment and audit-related information, but is not a full annual report or audit report itself. However, since it is an announcement about the audit firm appointment and not the audit report itself, it is more appropriate to classify it as Audit Report / Information (AR) rather than Annual Report (10-K) or Report Publication Announcement (RPA). FY 2026
2026-03-20 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.